Clinical Trials Logo

Caffeine Dependence clinical trials

View clinical trials related to Caffeine Dependence.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05323578 Completed - Caffeine Clinical Trials

Consumption Status of Caffeine and Adverse Effects Experience Among Anesthetists

Start date: April 18, 2022
Phase:
Study type: Observational

High-caffeine consumption has been increasing in physicians, frequently causing the most common symptoms such as tremor, insomnia, anxiety, and nervousness and rarely leading to serious adverse effects like seizure, acute mania, and stroke due to caffeine overdose. There have been no studies regarding analysis of high-caffeine consumption and its adverse effects among anesthetists.

NCT ID: NCT04560595 Completed - Anxiety Clinical Trials

Remote Guided Caffeine Reduction

Start date: September 10, 2020
Phase: N/A
Study type: Interventional

The purpose of this online research study is to determine whether or not a gradual caffeine reduction program developed at Johns Hopkins can help people reduce their caffeine use. The investigators will provide materials to help guide caffeine reduction and ask questions to track caffeine use over several weeks. The investigators will also assess how reducing caffeine may benefit common caffeine-related problems such as anxiety, sleep disturbances, and gastrointestinal distress. The study will also determine whether or not people like participating in this caffeine reduction program in an online format.

NCT ID: NCT03731286 Completed - Caffeine Dependence Clinical Trials

A Long-term Safety and Efficacy of EnXtra (E-AG-01) in Healthy Adults

Start date: November 23, 2018
Phase: N/A
Study type: Interventional

The present study has been proposed to investigate the long-term safety and efficacy of EnXtra in healthy adults habituated to caffeine.